Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

ClinicalTrials.gov ID: NCT00515164

Public ClinicalTrials.gov record NCT00515164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2 Study of the 20 mL Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study it to evaluate the efficacy and safety of the 20 mL BLVR System in patients with advanced upper lobe predominant emphysema.

Study identification

NCT ID
NCT00515164
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aeris Therapeutics
Industry
Enrollment
22 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
Oct 24, 2011

2007 – 2009

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Pulmonary Associates Phoenix Arizona 85006 —
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 —
Veritas Clinical Specialties, Ltd Topeka Kansas 66606 —
St Joseph's Medical Center Towson Maryland 21204 —
Akron Medical Center Akron Ohio 44302 —
Pulmonary, Allergy & Critical Care Medicine, Cleveland Clinic Foundation Cleveland Ohio 44195 —
Temple University Lung Center Philadelphia Pennsylvania 19140 —
Medical University of South Carolina Charleston South Carolina 29425 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00515164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2011 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00515164 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →